Amundi
LLY icon

Amundi’s Eli Lilly LLY Stock Holding History

Amundi’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.77B Sell
4,808,143
-246,882
-5% -$252M 1.39% 12
2026
Q1 		$4.65B Buy
5,055,025
+454,549
+10% +$461M 1.27% 11
2025
Q4 		$4.94B Buy
4,600,476
+74,574
+2% +$71.3M 1.34% 10
2025
Q3 		$3.82B Buy
4,525,902
+964,675
+27% +$718M 1.23% 10
2025
Q2 		$2.78B Sell
3,561,227
-1,391,901
-28% -$1.08B 0.96% 11
2025
Q1 		$3.91B Buy
4,953,128
+564,307
+13% +$470M 1.42% 8
2024
Q4 		$3.45B Sell
4,388,821
-150,867
-3% -$125M 1.2% 9
2024
Q3 		$4.15B Buy
4,539,688
+547,399
+14% +$492M 1.53% 5
2024
Q2 		$3.59B Sell
3,992,289
-73,442
-2% -$58.7M 1.37% 7
2024
Q1 		$3.04B Buy
4,065,731
+318,076
+8% +$226M 1.31% 8
2023
Q4 		$2.34B Sell
3,747,655
-654,058
-15% -$382M 1.05% 8
2023
Q3 		$2.67B Sell
4,401,713
-465,650
-10% -$240M 1.31% 8
2023
Q2 		$2.25B Sell
4,867,363
-815,450
-14% -$342M 1.14% 10
2023
Q1 		$2.06B Buy
5,682,813
+1,118,792
+25% +$377M 1.11% 9
2022
Q4 		$1.65B Sell
4,564,021
-360,714
-7% -$128M 0.9% 16
2022
Q3 		$1.63B Buy
4,924,735
+1,158,508
+31% +$367M 0.97% 11
2022
Q2 		$1.23B Buy
3,766,227
+34,190
+0.9% +$10.3M 0.99% 11
2022
Q1 		$1.15B Buy
3,732,037
+293,908
+9% +$75.6M 0.78% 18
2021
Q4 		$862M Sell
3,438,129
-165,350
-5% -$41.9M 0.55% 32
2021
Q3 		$833M Sell
3,603,479
-790,813
-18% -$195M 0.58% 29
2021
Q2 		$1.01B Buy
+4,394,292
New +$883M 0.7% 21

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Amundi's LLY Position: Q2 2026 in Review

Amundi reduced its Eli Lilly (LLY) stake by 4.9% in Q2 2026, selling an estimated $252M and leaving 4,808,143 shares worth $5.77B. The position accounts for 1.39% of the portfolio, ranked #12.

Amundi first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Amundi held 4,808,143 shares of Eli Lilly worth $5.77B as of Q2 2026.
  • Amundi sold 246,882 Eli Lilly shares in Q2 2026, an estimated $252M.
  • Eli Lilly made up 1.39% of Amundi's portfolio in Q2 2026, its #12 holding.
  • Amundi first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.